Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest
Niklas Nielsen(Lund University), Hans Friberg(Lund University), Christian Hassager(University of Copenhagen), Tobias Cronberg(Lund University), Janneke Horn(Amsterdam University Medical Centers), Jesper Kjærgaard(University of Copenhagen), Matty Koopmans(Medisch Centrum Leeuwarden), Jørn Wetterslev(Copenhagen University Hospital), Malin Rundgren(Skåne University Hospital), Per Winkel, Lars Køber(University of Copenhagen), Jørund Langørgen(Haukeland University Hospital), Jan Hovdenes(Oslo University Hospital), Christian Rylander(Uppsala University), Michael Wanscher(Copenhagen University Hospital), Gisela Lilja(Lund University), Michaël Kuiper(Medisch Centrum Leeuwarden), Matt P. Wise(University Hospital of Wales), Yvan Gasche(University Hospital of Geneva), Iole Brunetti(Istituti di Ricovero e Cura a Carattere Scientifico), Ondřej Šmíd(General University Hospital in Prague), David Erlinge(Lund University), Anders Åneman, John Bro‐Jeppesen(Copenhagen University Hospital), Nicole P. Juffermans(Erasmus MC), Pascal Stammet(Centre Hospitalier de Luxembourg), Jacob Eifer Møller(University of Southern Denmark), Tommaso Pellis(Azienda Ospedaliera Santa Maria Degli Angeli), Søren Boesgaard(Copenhagen University Hospital), Christopher D Hingston(University Hospital of Wales), Christophe Werer(Centre Hospitalier de Luxembourg), J. F. Bugge(Oslo University Hospital), Nawaf Al-Subaie
Cited by 2,763
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
|New England Journal of Medicine|2003|2.5k